Chronic venous insufficiency: Worldwide results of the RELIEF study

Angiology

Volumn 53, Issue 3, 2002, Pages 245-256

  Jantet, G ^a  

^a Union Internationale de Phlébologie ^*  (France)

Author keywords

Alvenor; Ardium; Arvenum 500; Capiven; Daflon 500 mg; Detralex; Elatec; Variton; Venitrol

Indexed keywords

DAFLON;

ADULT; AGE; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; EDEMA; FEMALE; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PARAMETER; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOM; TIME; VALIDATION PROCESS; VENOUS REFLUX;

ADULT; ANALYSIS OF VARIANCE; CHRONIC DISEASE; DIOSMIN; EDEMA; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 0036092803     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970205300301     Document Type: Article

References (63)

1. Investigation of chronic venous insufficiency: A consensus statement
2. The management of chronic venous disorders of the leg: An evidence-based report of an international task force
3. Varicose veins pilot study
4. The epidemiology of varicose veins: A survey of Western Jerusalem
5. Prévalence des varices primitives des membres inférieurs dans une population randomisée de la Sicile occidentale
6. Venous thromboembolism and other venous disease in the Tecumseh community Health Study
7. Varicose veins and chronic venous insufficiency: Prevalence and risk factors in 4,376 subjects in the Basle Study II
8. La maladie veineuse en France: Un problème de santé publique méconnu
9. Socioeconomic impact of chronic venous insufficiency and leg ulcers
10. Chronic venous insufficiency of the lower limbs and its socioeconomic significance
11. Prevalence of chronic leg ulceration and severe chronic venous disease in Western countries
12. Hemodynamic basis of stasis ulceration - A hypothesis
13. Hemodynamic deterioration in chronic venous disease
14. Venous reflux: Quantification and correlation with the clinical severity of chronic venous disease
15. Noninvasive assessment of primary and secondary varicose veins
16. Prevalence of venous reflux in the general population on duplex scanning: The Edinburgh Vein Study
17. The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: The Edinburgh Vein Study
18. Venous elasticity after treatment with Daflon 500 mg
19. The human saphenous vein in pharmacology: Effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine-induced contraction
20. Pharmacodynamic properties and therapeutic efficacy of Daflon 500 mg
21. Double-blind study of the pharmacodynamic and clinical activities of 5682SE in venous insufficiency. Advantages of the new micronized form
22. A double-blind, placebo-controlled trial of a new veno-active fraction (S5682) in the treatment of symptomatic capillary fragility
23. The inflammatory reaction during venous hypertension in the rat
24. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study
25. Microlymphography assessment of Daflon 500 mg activity in patients with chronic venous insufficiency
26. Activité lymphagogue du Daflon 500 mg in vivo chez les chiens
27. Control of lymphatic pumping: Interest of Daflon 500 mg
28. Mesure comparative de l'absorption orale de deux formes de diosmine (micronisée - Daflon 500 mg et non micronisée) chez le volontaire sain par l'accélérateur de spectrométrie de masse
29. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized diosmin tablets after oral administration to healthy volunteers analyzed by Accelerator Mass Spectrometry
30. Evaluation of a new venoactive micronized flavonoid fraction (S5682) in symptomatic disturbances of the venolymphatic circulation of the lower limb: A double-blind, placebo-controlled study
31. Chronobiology and clinical activity of Daflon 500 mg in chronic venous insufficiency
32. A long term treatment with a venotropic drug
33. RELIEF Study: First consolidated European data
34. Efficacy of Daflon 500 mg in chronic venous leg ulcer healing. A double-blind, randomized, controlled versus placebo trial in 107 patients
35. The beneficial augmentative effects of micronized purified flavonoid fraction (MPFF) on the healing of leg ulcers; An open multicentre, controlled, randomized study
36. Measuring disease-specific quality of life in clinical trials
37. Construction and validation of a specific health-related quality of life questionnaire in chronic venous insufficiency on everyday life
38. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ)
39. Reporting standards in venous disease: An update
40. A comparison of photoplethysmography, Doppler ultrasound and duplex scanning in the assessment of venous disease
41. Intérêt de la photo-pléthysmographie dans le diagnostic de l'insuffisance veineuse profonde
42. Comparison of conditional quality of life terminology and visual scale measurements
43. Visual analogue pain rating scales
44. Edema and leg volume: Methods of assessment
45. Reliability study of the Leg-O-Meter® in patients suffering from venous insufficiency of lower limbs
46. Reliability study of Leg-O-Meter, an improved tape measure device in patients with chronic venous insufficiency of the leg
47. The application of the principle of intention to treat to the analysis of clinical trials
48. Venous wall function in the pathogenesis of varicose veins
49. Venous distensibility in patients with varicose veins
50. Venous morphology predicts class of chronic venous insufficiency
51. Microcirculation inflammation in chronic venous insufficiency: Current status and future directions
52. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population
53. The 1999 French Venous Disease Survey: Epidemiology, management, and patient profiles
54. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey
55. Symptomatology of vein disease